Lyme neuroborreliosis
ICD-10 A69.2 · ICD-11 1C1G.10

Treatment of Lyme Neuroborreliosis in Children Presenting with Encephalomeningitis Symptoms

Clinical Scenario

This protocol is for children diagnosed with Lyme neuroborreliosis who present with symptoms of encephalomeningitis — including vomiting or dysphagia — that prevent reliable oral administration and require intravenous initiation of treatment.

Patient Population

The key defining features are pediatric age and active encephalomeningitis symptoms. Vomiting or dysphagia in a child with Lyme neuroborreliosis creates a practical barrier to oral therapy at the outset, establishing the need for an IV approach from the start.

Treatment Approach — Partial Overview

Management is initiated intravenously, with a third-generation cephalosporin used first. Once the encephalomeningitis symptoms have resolved, treatment transitions to an oral agent. The complete sequencing, agent selection, and treatment duration are available in the full structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.3205/000349

If treatment is to begin intravenously due to symptoms of encephalomeningitis, such as vomiting or dysphagia, third-generation cephalosporins should be administered first.

Once these symptoms have subsided, an oral doxycycline should be administered for a total of 2 or 3 weeks.

View source ↗